Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Entecavir plus Adefovir in LAM-resistant Chronic Hepatitis B
NCT02482272Phase 4Unknown
- Sponsor
- Asan Medical Center
- Start
- May 2015
- Primary completion
- Jan 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of entecavir in Chronic Hepatitis B (CHB), sponsored by Asan Medical Center. Status: unknown.
02
Drugs
entecavir
03
Conditions
Chronic Hepatitis B (CHB)
Beyond the preview
Go deeper on NCT02482272.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02482272.